Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine for Opioid Reduction in Pediatric Upper Extremity Fracture Surgery
NCT07552766Phase 4Recruiting
- Sponsor
- Nemours Children's Health
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in bone fracture (Fx) (2 arms), sponsored by Nemours Children's Health. Primary endpoint: Total perioperative opioid consumption. Started Jun 2026; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
bone fracture (Fx)
Beyond the preview
Go deeper on NCT07552766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07552766.